Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Vertex Pharmaceuticals Inc. buy Citigroup Inc.

Vertex Pharmaceuticals Inc.
Start price
€435.00
10.03.26 / 50%
Target price
€503.22
10.03.27
Performance (%)
-1.33%
Price
€429.20
07.08.26
Summary
This prediction is currently active. With a performance of -1.33%, the BUY prediction for Vertex Pharmaceuticals Inc. by Citigroup_Inc_ is down slightly. This prediction currently runs until 10.03.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Vertex Pharmaceuticals Inc. 3.759% 3.759%
iShares Core DAX® 2.573% 3.502%
iShares Nasdaq 100 4.858% 0.654%
iShares Nikkei 225® 5.590% -0.246%
iShares S&P 500 3.250% 2.083%

Comments by Citigroup_Inc_ for this prediction

In the thread Vertex Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) -1.33%
Target price 503.217
Change
Ends at 10.03.27

Vertex Pharmaceuticals (VRTX) had its price target raised by Citigroup Inc. from $575.00 to $585.00. They now have a "buy" rating on the stock.
Ratings data for VRTX provided by MarketBeat

Citigroup Inc. 
0
Report Share
10.03.26

Stopped prediction by Citigroup_Inc_ for Vertex Pharmaceuticals Inc.

buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€346.50
02.10.25
€489.84
02.10.26
23.87%
07.08.26

Citigroup Inc. 
02.10.25 50%
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€470.80
14.11.24
€545.96
14.11.25
-19.47%
15.11.25

Citigroup Inc. 
14.11.24 50%